These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 24016359)
1. Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion model. Wijeratne AB; Manning JR; Schultz Jel J; Greis KD J Proteome Res; 2013 Oct; 12(10):4268-79. PubMed ID: 24016359 [TBL] [Abstract][Full Text] [Related]
2. Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction. Manning JR; Wijeratne AB; Oloizia BB; Zhang Y; Greis KD; Schultz JEJ J Mol Cell Cardiol; 2020 Nov; 148():1-14. PubMed ID: 32853649 [TBL] [Abstract][Full Text] [Related]
3. Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction. Manning JR; Perkins SO; Sinclair EA; Gao X; Zhang Y; Newman G; Pyle WG; Schultz Jel J Am J Physiol Heart Circ Physiol; 2013 May; 304(10):H1382-96. PubMed ID: 23479264 [TBL] [Abstract][Full Text] [Related]
4. The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling. Liao S; Porter D; Scott A; Newman G; Doetschman T; Schultz Jel J J Mol Cell Cardiol; 2007 Jan; 42(1):106-20. PubMed ID: 17150229 [TBL] [Abstract][Full Text] [Related]
5. The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury. Liao S; Bodmer JR; Azhar M; Newman G; Coffin JD; Doetschman T; Schultz Jel J J Mol Cell Cardiol; 2010 Jun; 48(6):1245-54. PubMed ID: 20116383 [TBL] [Abstract][Full Text] [Related]
6. Research resource: identification of novel growth hormone-regulated phosphorylation sites by quantitative phosphoproteomics. Ray BN; Kweon HK; Argetsinger LS; Fingar DC; Andrews PC; Carter-Su C Mol Endocrinol; 2012 Jun; 26(6):1056-73. PubMed ID: 22570334 [TBL] [Abstract][Full Text] [Related]
7. The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2. House SL; Melhorn SJ; Newman G; Doetschman T; Schultz Jel J Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H354-65. PubMed ID: 17337596 [TBL] [Abstract][Full Text] [Related]
8. RABA (reductive alkylation by acetone): a novel stable isotope labeling approach for quantitative proteomics. Zhai J; Liu X; Huang Z; Zhu H J Am Soc Mass Spectrom; 2009 Jul; 20(7):1366-77. PubMed ID: 19419886 [TBL] [Abstract][Full Text] [Related]
9. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. House SL; Bolte C; Zhou M; Doetschman T; Klevitsky R; Newman G; Schultz Jel J Circulation; 2003 Dec; 108(25):3140-8. PubMed ID: 14656920 [TBL] [Abstract][Full Text] [Related]